Breast cancer is a heterogeneous disease and can be categorized into different subtypes based on expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2), which have different prognosis and treatment [1]. This evidence concerns the gene PGR and breast carcinoma.